Advisory Council

The membership of the ACS may elect additional Council members to advise the executive council and provide adequate representation of the membership, for example in terms of cytometry field (research, clinical, industrial) or geographical area (Australia, New Zealand). Additional Council members shall serve until the next Annual General Meeting.

Current Advisory Council:

Dr Anna Brooks
Councillor ex officio, Conference Chairperson

AnnaDr Anna Brooks holds a BCA (management) and a PhD in Immunology and is a Senior Research Fellow with the Maurice Wilkins Centre at the University of Auckland, New Zealand. She has been using flow cytometry for most of her research years, but has also been managing and enhancing the capabilities of the flow cytometry facility housed in Professor Rod Dunbar’s immunology lab (School of Biological Sciences) for the last 8 or so years. Anna recently launched and now directs this platform, Auckland Cytometry, as a shared resource facility for the Faculty of Science. In addition, Anna is currently facilitating a collaboration with Auckland Genomics to establish a pipeline for single cell transcriptomics (scRNAseq), the first of its kind in New Zealand.

Anna is experienced in multicolour panel development, especially for the characterisation of complex cellular populations in digested human tissues. Anna’s current research interest lies in dissecting the heterogeneity of mesenchymal cells in human adipose tissue using both flow cytometric and proteogenomic techniques (CITEseq/scRNAseq). In addition, Anna is an associate investigator on an on-going international collaboration with the role of developing multicolour panels (20+ colours) to monitor immune responses for clinical trials.

Anna is an active member of the international flow cytometry community and regularly attends and presents at both cytometry and research interest conferences. Anna is passionate about teaching flow cytometric best practices and has presented and facilitated a number of workshops, including at the international CYTO conferences. She has also sat on a number of conference organising and national grant reviewing committees. As well as ACS, Anna is also a member of the Australian Society for Immunology, the Australasian Society for Stem Cell Research, the International Society for Advancement of Cytometry and the International Society for Stem Cell Research

Dr Sheree Bailey

2018 ACS_Sheree BaileyDr Sheree Bailey is the Head of Unit in the Flow Cytometry Facility, SA Pathology at Flinders Medical Centre and Senior Lecturer, Flinders University. The SA Pathology diagnostic unit specialises in leukaemia and lymphoma and minimal residual disease analysis. Highlights include the implementation of standardised flow cytometry assays to assess the level of minimal residual disease in chronic lymphocytic leukaemia and more recently, in myeloma patients. Sheree is a member of the RCPA Immunophenotyping Advisory Committee.

Sheree also manages the Flinders University Cytometry Facility at Flinders Medical Centre and she has completed a Graduate Diploma of Management. She completed her PhD at Flinders University (part time) in 2017 demonstrating skills in multicolour panel design and data analysis, apoptosis, phosphoprotein and calcium signaling and ImageStream X analysis.

Sheree is a past Treasurer of the ACS (2004) and was Clinical Program Coordinator for the 2018 Annual Scientific meeting in Adelaide. She is also a member of the ACS Clinical Guidelines Taskforce. Sheree is keen to continue the promotion of education and training by the ACS and to develop collaborations between ACS members in clinical cytometry.

Michelle Petrasich


Michelle Petrasich has been the Scientific Leader of the Immunophenotyping and Transplantation Laboratory at Auckland City Hospital, NZ, since 1999. Prior to this she was Second in change of the Flow cytometry laboratory for 9 years when it was located in the Molecular Medicine department at the Auckland School of Medicine.

Michelle has convened or been involved in the organisation of BMTSAA and HSANZ scientific meetings, NZIMLS workshops in flow cytometry, NZ Flow Cytometry Group Scientific Meetings, and the NZ ACS Roadshow.

She has been a moderator for the Haematology Examination, BMedLab Sc, and a reviewer for the NZIMLS Institute Scientific journal. She was on the ACS Guidelines Taskforce to oversee the update and review of ASC Clinical flow cytometry CD34 guidelines. In the laboratory her particular areas of interest are education and method development, particularly in the area of Minimal residual disease studies. Her laboratory is a COG accredited reference laboratory for Paediatric B-ALL in NZ, and she has set up clinical testing for adult AML MRD, in collaboration with the UK MRC AML19 reference centre. In 2017 she was awarded the ADHB Allied Health Scientific and Technical Innovation award for this work.

In 2013, Michelle passed the International Cytometry Certification exam (ICCE).

When she first qualified, clinical flow cytometers had not yet hit the scene, research flow cytometers filled half a room, were water cooled and had 2 colours, and Immunophenotyping was performed using fluorescence microscopy.

Kylie Price

KylieAs Head of Research Technology at the Malaghan Institute of Medical Research (MIMR) Kylie has worked in cytometry for 13 years and has been responsible for driving the creation of a state-of-the-art cytometry facility at New Zealand’s leading independent biomedical institute, which includes flow and spectral cytometry, microscopy and immunohistochemistry.  Managing a shared resource laboratory with three staff, she provides more than 70 MIMR research scientists with expertise and access to cytometry instrumentation to advance their research goals.

Kylie has been credited with pioneering the use of multicolour flow cytometry and spectral cytometry within New Zealand and enjoys using cytometry for as wide a range of research applications as possible.  She has analysed and sorted: side-population cells from primary human brain tissue, bacteria from Antarctic sea-ice, bovine sperm and algal spores, to name a few.  She is the first New Zealander elected to the International Society for Advancement of Cytometry (ISAC) council (2018-2024), a member of ISAC’s Proliferation Content Author Group for CYTO University and the Live Education Task Force, she is a Past President of the Australasian Cytometry Society (2015-2016), she also played a crucial role instigating and facilitating CYTOAsia Singapore 2016 and is actively involved in planning CYTOAsia Shanghai 2019.

Through collaboration, she has developed innovative cytometry solutions to address researcher needs, including cell preparation, cell analysis, panel design, data interpretation and presentation. In 2012, Kylie arranged a “technology transfer sabbatical” in Spain, spending time in some of the most advanced flow cytometry facilities in Spain and Europe.  The aim was both to gain a broader range of cytometry experience, as well as to train cytometry users in Spain from a wide range of scientific backgrounds, about the power, advancements and flexibility of flow cytometry.  This experience also provided her with a vision and roadmap for how to grow the cytometry core facility at MIMR in the future.

Robert Salomon

Rob Salomon is an experienced cytometerist and technical scientist that is motivated to drive the advancement of science through the appropriate use of technology. This involves both the effective utilization of current technology as well as the development and/or application of novel technologies. Rob is a scientifically trained technologist that has driven large projects and built effective teams to leverage cutting-edge technologies for the advancement of science. He is inspired to:

rob salomon2 (1)

  1. Advance Science
  2. Progress the understanding of disease and biological processes
  3. Help researchers achieve their goals
  4. Work within as well as lead cohesive teams where highly skilled specialists can work in a collaborative manner to achieve outcomes that would not be possible individually
  5. Leverage technological solutions to help answer big questions
  6. Identify synergies between previously disparate technologies to provide seamless solutions to simplify complex processes

Since 2015, Rob has been working to advance the field of Genomic Cytometry. This is evidenced by his driving role in the design, planing and implementation of the Garvan-Weizmann Centre for Cellular Genomics. Rob, along with the team he built and with support from the Garvan Institute, successfully conceived, funded and built the centre. The centre is the only one of its kind in Australia and is unique in the world in that it brings the previous disparate modalities of cytometry, microfluidics, genomics and bioinformatics under the one roof. Most recently, Rob has been Working at the University of Technology Sydney with the Institute of Biomedical Materials and Devices (IBMD) and the Children’s Cancer Institute of Australia (CCIA) where he lead the technology design for the recently announced ACRF Child Canner Liquid Biopsy Program.

Rob has been involved with the ACS since beginning in cytometry in 2004. He has filled a number of positions with the ACS including, Website committee member, Treasurer and is currently the ACS Industry and Innovation liaison member. In his role with ACS he is passionate about bringing new technologies and approaches to the field of Cytometry and is looking to provide support for innovation and to improve connections between industry and academia.